FDA Inspection
Syntho Pharmaceuticals, Inc.Syntho Pharmaceuticals, Inc. – FDA Inspection, Mar 1, 2024
Record Details
This FDA Inspection record concerns Syntho Pharmaceuticals, Inc., with an inspection on March 1, 2024, issued by the New York District Office, covering human drugs.
View Company Profile
ID · fd1dffae-5a68-471f-b850-913210a058cf
Inspection Facts
- Inspection number
- 1231554
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.46(b)Equipment for Environmental Control
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Syntho Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Syntho Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.